Startups
ReHaptix is a clinically validated mHealth application assisting patients and healthcare professionals in monitoring the rehabilitation progress of patients suffering from upper limb impairments caused by a neurological injury, such as stroke, multiple sclerosis or Parkinson's disease.
Overview
Location
Switzerland, Zurich
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| VentureLab | venturelab.swiss |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 22, 2018 | Accessing the efficacy of treatments thanks to tests combined with patients' data | |
| Jan 15, 2014 | Von unbemannten Flugobjekten, Musiklehrern der Zukunft und Analysemethoden für die Krebsmedizin | |
| Jan 6, 2014 | ETH spin-offs: a promising investment | |
| Dec 2, 2013 | ReHaptix gewinnt bei venture kick |
Reviews 0
FAQ about ReHaptix GmbH
Who has invested in ReHaptix GmbH?
Parsers VC lists 2 investors of ReHaptix GmbH, among them VentureLab.
What has the press written about ReHaptix GmbH?
Parsers VC has collected 5 articles mentioning ReHaptix GmbH, among them “Accessing the efficacy of treatments thanks to tests combined with patients' data” (Jan 22, 2018) and “Von unbemannten Flugobjekten, Musiklehrern der Zukunft und Analysemethoden für die Krebsmedizin” (Jan 15, 2014).
Is ReHaptix GmbH still active?
Yes, ReHaptix GmbH is active; its latest activity on Parsers VC dates from Dec 28, 2018.